![Sijmen de Vries](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: - $ in data 31/07/2026
Sijmen de Vries is currently Chief Executive Officer at Pharming Intellectual Property BV, Non-Executive Director at Sylus Pharmaceuticals Ltd. since 2010, Independent Non-Executive Director at Biodexa Pharmaceuticals Plc since 2014, and Finish Partner at BioConnection BV.
Former roles include Chief Executive Officer at Morphochem AG and 4-Antibody AG, Executive Director at Pharming Group NV from 2008 to 2025, and Non-Executive Director at Biodexa Ltd. from 2004 to 2015.
Education includes a doctorate from the University of Amsterdam and an MBA from Ashridge Business School.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 12/03/2026 | 0 ( -.--% ) | - $ | 31/07/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| BIODEXA PHARMACEUTICALS PLC | Direttore/Membro del Consiglio | 13/11/2014 |
Sylus Pharmaceuticals Ltd. | Direttore/Membro del Consiglio | 21/06/2010 |
Pharming Intellectual Property BV
 Pharming Intellectual Property BV Trucks/Construction/Farm MachineryProducer Manufacturing Manufactures milking equipment | Amministratore Delegato | - |
BioConnection BV
 BioConnection BV BiotechnologyHealth Technology Provides biopharmaceutical services | Corporate Officer/Principal | - |
| Società | Posizione | Fine |
|---|---|---|
| PHARMING GROUP N.V. | Amministratore Delegato | 04/03/2025 |
Midatech Ltd.
 Midatech Ltd. BiotechnologyHealth Technology Engages in discovery and the development of nanomedicine pharmaceutical products | Direttore/Membro del Consiglio | 13/03/2015 |
4-Antibody AG
 4-Antibody AG Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | Amministratore Delegato | - |
Morphochem AG
 Morphochem AG Miscellaneous Commercial ServicesCommercial Services Discovers and develops drugs | Amministratore Delegato | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 10 |
|---|---|
Pharming Group NV
 Pharming Group NV Pharmaceuticals: MajorHealth Technology Develops and commercializes protein replacement therapies and precision medicines | Health Technology |
Morphochem AG
Morphochem AG Miscellaneous Commercial ServicesCommercial Services Discovers and develops drugs | Commercial Services |
University of Amsterdam
 University of Amsterdam Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
4-Antibody AG
4-Antibody AG Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | Health Technology |
Ashridge Business School
 Ashridge Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioConnection BV
BioConnection BV BiotechnologyHealth Technology Provides biopharmaceutical services | Health Technology |
Midatech Ltd.
Midatech Ltd. BiotechnologyHealth Technology Engages in discovery and the development of nanomedicine pharmaceutical products | Health Technology |
Sylus Pharmaceuticals Ltd. | |
Biodexa Pharmaceuticals Plc
 Biodexa Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Designs and manufactures nanomedicines | Health Technology |
Pharming Intellectual Property BV
Pharming Intellectual Property BV Trucks/Construction/Farm MachineryProducer Manufacturing Manufactures milking equipment | Producer Manufacturing |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
